Convergence and Evotec form integrated pain alliance Cambridge, UK, 31 March 2014: Convergence Pharmaceuticals Holdings Limited (“Convergence”), the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today...
Chimerix Appoints Lisa Ricciardi to Board of Directors DURHAM, N.C., April 1, 2014 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the appointment...
Intarcia Secures Second Landmark Private Financing of $200 Million – Strengthens Position To Complete Phase 3, Prepare For Launch, and Build Pipeline – Promising first interim phase 3 data for ITCA 650 in type 2 diabetes, combined with robust execution against...
Spiracur Announces FDA Clearance of its SNaP Wound Care System Dressings with Hyperbaric Oxygen Therapy SUNNYVALE, Calif., April 1, 2014 – Spiracur today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the SNaP® Wound Care Dressing (with fittings...
Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs REDWOOD CITY, Calif., April 2, 2014 (GLOBE NEWSWIRE) — Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of...
Premier, Inc. Identifies Kit Check as “Technology Breakthrough Product” – awards exclusive agreement for pharmacy kit medication tracking solution Washington, DC – April 2, 2014 – Premier, Inc., a leading healthcare improvement company uniting an...
Recent Comments